Doctors Sue FDA to Protect Ivermectin as COVID-19 Treatment

Doctors Sue FDA to Protect Ivermectin as COVID-19 Treatment — FLCCC founder and Chief Science Officer, Dr. Paul Marik; FLCCC Clinical Advisor, Dr. Mary Talley Bowden; and Dr. Robert L. Apter challenge the Food and Drug Administration regarding ivermectin as a COVID treatment. The plaintiffs, “argue the FDA acted outside of its authority and illegally interfered with their ability to practice medicine by directing the public, including health professionals and patients, to not use ivermectin, a drug that has received full FDA approval for human use.”